We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2026
Programme
Gynaecological cancers 2
15 May 2026 - 19 May 2026
Stockholm, Sweden
ESTRO 2026
Session
Sunday
May 17
09:00 - 10:00
K2
Gynaecological cancers 2
Co-Chair:
Asma Sarwar
,
United Kingdom
;
Chair:
Sophie Espenel
,
France
Session Type:
Poster Discussions
Track:
Clinical
Journey:
Add to
My Programme
09:00 - 10:00
Oligometastatic Ovarian Cancer: Why the Radiation Oncologist Should Be Involved Sooner—Outcomes Stratified by ESTRO-EORTC Criteria
Presenter
:
Donato Pezzulla
,
Italy
Presentation Number:
-688
09:00 - 10:00
Quantification of vertebral dose-response and bone preservation in pelvic radiotherapy: prospective evidence from RadBone randomised controlled trial
Presenter
:
Artemis Bouzaki
,
United Kingdom
Presentation Number:
-2196
09:00 - 10:00
Radiation-induced chronic haemorrhagic cystitis after cervical cancer radiotherapy: temporal course, impact of interventions and cost analysis.
Presenter
:
Ranjan Subramani
,
India
Presentation Number:
-1648
09:00 - 10:00
From distress to desire: preliminary results of a prospective comparative study on psychological and sexual outcomes in cervical cancer
Presenter
:
Loredana Dinapoli
,
Italy
Presentation Number:
-2175
09:00 - 10:00
Lumbopelvic bone and muscle doses and incidence of back pain in EMBRACE-II: results from Indian and Danish locally advanced cervical cancer cohorts.
Presenter
:
Supriya Chopra
,
India
Presentation Number:
-2581
09:00 - 10:00
Image-Guided Reirradiation for Recurrent Non-Endometrial Gynecologic Cancers: A Multi-Institutional Real-World Analysis
Presenter
:
Mateusz Bilski
,
Poland
Presentation Number:
-664
09:00 - 10:00
ITV-Free Online Adaptive Adjuvant Pelvic Radiotherapy for Endometrial cancer: Feasibility, Dosimetric Advantages, and Early Oncologic Outcomes.
Presenter
:
Marcel Fang
,
Israel
Presentation Number:
-4119
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.